Trends in Arthroplasty: A Detailed Data Report Powered by OE M.I.N.D.
December 5, 2022
Trends in Arthroplasty: A Detailed Data Report Powered by OE M.I.N.D.
Authored By: Yaping Chang, Steve Philips, Ellen Scholl, Selina Bains, Mohit Bhandari On Behalf of OrthoEvidence
Highlights
- OE M.I.N.D. contains data from nearly 1,600 randomized control trials related to arthroplasty.
- Collectively, these studies have recruited more than 2.7 million patients and researched 52 conditions across 43 different anatomical regions.
- The most popular content concerns osteoarthritis, rheumatic arthritis, fracture, knee, hip, total hip arthroplasty, total knee arthroplasty, and tranexamic acid.
- In published studies related to arthroplasty, osteoarthritis as a condition, tranexamic acid and total knee arthroplasty as treatments, operative time as an outcome and a follow-up duration of 12 months were most frequently reported.
- Using data from clinicaltrials.gov, we find that there are 262 ongoing studies related to arthroplasty aiming to recruit over 45,000 patients. The top conditions being studied are those related to osteoarthritis and fractures.
- Since 2002, the manufacturers that have published the most research associated with arthroplasty are Zimmer-Biomet, DePuy Synthes, Stryker, Smith & Nephew, and Johnson & Johnson.
Arthroplasty is a surgical procedure for reconstruction or replacement of a joint, in order to restore joint function and improve pain (Fenlin et al., 1998; Pappas et al., 2022). Knee and hip arthroplasties are among the most commonly performed surgeries worldwide in the developed countries (Pappas et al., 2022). The 2022 Canadian Joint Replacement Registry (CJRR) report analyzed approximately 110,000 hip or knee arthroplasties...
To view the full content, login to your account,
FREE TRIAL LOGIN Forgot Password?SHARE THIS OE ORIGINAL
Loading...
Join the Conversation
Please Login or Join to leave comments.